Latest / Community Health Media
Dr. Alison Conlin & Dr. Heather McArthur - DB-11 & DB-05: Rewriting Neoadjuvant & Adjuvant HER2+ Breast Cancer Strategy
Recorded live, this in-depth conversation features Dr. Alison Conlin and Dr. Heather McArthur as they break down the evolving role of antibody–drug conjugates in early-stage HER2-positive breast cancer.
The discussion dives into DESTINY-Breast 11 and DESTINY-Breast 05, exploring how trastuzumab deruxtecan is challenging long-standing neoadjuvant and adjuvant paradigms. From pathologic complete response and invasive disease-free survival to toxicity management, ILD monitoring, and patient selection, this episode tackles how clinicians are balancing escalation and de-escalation in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.